1. Pink Sheet
  2. >>Geography
  3. >>International

How To Make International Pull Incentives Work In Fight Against AMR

 
• By Francesca Bruce

Global action on delivering pull incentives for the development of new antibiotics is urgently required, according to a new report that sets out how countries could join together to make incentives attractive enough for companies to invest in this space.

Action required - word abstract in vintage letterpress wood type
Action is urgently needed to address antimicrobial resistance • Source: Shutterstock

Countries around the world could come together to fund a global pull incentive, worth around $4.2bn, to encourage the development of new antibiotics, according to a new industry-sponsored report that says the need for international action on antimicrobial resistance (AMR) is increasingly urgent.

The report, Incentivising new antibiotics, from the UK Office of Health Economics, describes a “globally aligned, value-based, fully delinked pull incentive” where payers provide manufacturers with a subscription fee based...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from International

More from Geography

Canada Cuts Red Tape With Single Ethics Review For Trials

 
• By Neena Brizmohun

A new research ethics review system for multi-site clinical trials in Canada is expected to help improve study start-up times, avoid unnecessary duplication and boost the country’s competitiveness on a global stage.

EMA Official Clarifies Benefits And Limitations Of Innovation Pathways

 
• By Eliza Slawther

A European Medicines Agency official provided an overview and update of the support the EMA offers developers of innovative products and discussed, among other things, its Innovation Task Force, Quality Innovation Group and a scientific advice pilot for clinical trials.

EU Emergency Response Authority Needs Bigger Budget To Address Health Threats, Says Industry

 
• By Eliza Slawther

The EU must renew the mandate of its Health Emergency Response Authority to support medicine stockpiles and enable agile manufacturing to combat antimicrobial resistance and chemical, biological, radiological and nuclear threats, says trade organization EUCOPE.